硫胺衍生型银河胺选择性地准了加勒-9N终端域中的未开发的结合部位
Mukul Mahanti1, Sofi Gummesson1, Anders Sundin1
1Department of Chemistry, Lund University, Box 124, SE-221 00 Lund, Sweden.
Bioorganic & medicinal chemistry
|November 16, 2024
概括
研究人员开发了新的硫胺衍生型银酸,发现了一种强效和选择性抑制剂,用于 galectin-9N. 这种化合物为研究加勒-9提供了有价值的工具.
科学领域:
- 碳水化合物化学 碳水化合物化学
- 药用化学 医学化学
- 结构生物学 结构生物学
背景情况:
- 盖莱克是一种beta-galactoside结合蛋白的家族,涉及到各种生物过程.
- 准特定的质素,如质素-9N,对于理解它们的作用和开发治疗方法至关重要.
- 开发选择性抑制剂仍然是一个挑战,因为加勒素家族成员之间保留了结合点.
研究的目的:
- 为了合成和评估新的硫胺衍生型银酸化物作为潜在的加勒胺抑制剂.
- 为了识别具有高亲和力和对特定加勒子类型的选择性化合物,特别是加勒-9N.
- 通过分子动力学模拟,阐明选择性抑制剂的结合机制.
主要方法:
- 合成了硫胺衍生型银酸的四种定向和定位变体.
- 合成化合物的体外评价与人类胆素 (胆素-1, -3, -4C, -7, -8N, -8C, -9N, -9C) 的一个小组对比.
- 分子动态模拟以调查抑制剂-蛋白相互作用和结合点互补性.
主要成果:
- 一种合成的化合物,甲基3-{4-[2-(phenylsulfonylamino) -phenyl]-triazolyl}-3-deoxy-α-d-galactopyranosides,与其非硫胺对应物相比,对加列-9N的亲和力是6-15倍.
- 分子动力学模拟揭示了一种独特的结合模式,其中硫胺部分与加勒-9N的非保存区域相互作用.
- 鉴定到的抑制剂对其它测试过的 galectin-9N 具有前所未有的选择性.
结论:
- 新型硫胺衍生型银酸可以作为加勒-9N的强效和选择性抑制剂.
- 由硫胺组介导的独特结合相互作用为实现高选择性提供了一种策略.
- 这些选择性加勒-9N抑制剂代表了研究加勒生物学的有价值的化学探针.
相关概念视频
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Glucose Transporters
22.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Protein Glycosylation
6.8K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.8K


